Humana (HUM)
(Real Time Quote from BATS)
$279.79 USD
-0.13 (-0.05%)
Updated Nov 4, 2025 12:48 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Humana Inc. has a PEG ratio of 1.87 compared to the Medical - HMOs industry's PEG ratio of 1.27.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its growth rate over the past 12 months. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
HUM 279.79 -0.13(-0.05%)
Will HUM be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for HUM based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for HUM
Why Humana (HUM) is a Top Momentum Stock for the Long-Term
Cigna (CI) Reports Next Week: Wall Street Expects Earnings Growth
HUM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Humana (HUM) Expected to Beat Earnings Estimates: Should You Buy?
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Other News for HUM
Humana Q3 2025 Earnings Preview
Insights into Humana's Upcoming Earnings
Is HUM gaining bullish strength? Hammer Candlestick shows up after advancing 0.62%
Fell Below 20 Day Moving Average appears for HUM after 2.6% move
U.S. Health Insurer Shares Stumble After Q3 Earnings As Cost Pressures Mount